Literature DB >> 21820293

Variation in volume definition between UK head and neck oncologists treating oropharyngeal carcinoma.

L Pettit, A Hartley, S J Bowden, H Mehanna, J Glaholm, J Cashmore, P Sanghera.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21820293     DOI： 10.1016/j.clon.2011.07.006

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  5 in total

1.  Can radiobiological parameters derived from squamous cell carcinoma of the head and neck be used to predict local control in anal cancer treated with chemoradiation?

Authors:  L Pettit; S Meade; P Sanghera; J Glaholm; J I Geh; A Hartley
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

Review 2.  Target Definition in MR-Guided Adaptive Radiotherapy for Head and Neck Cancer.

Authors:  Mischa de Ridder; Cornelis P J Raaijmakers; Frank A Pameijer; Remco de Bree; Floris C J Reinders; Patricia A H Doornaert; Chris H J Terhaard; Marielle E P Philippens
Journal:  Cancers (Basel)       Date:  2022-06-20       Impact factor: 6.575

3.  Primary tumor volume delineation in head and neck cancer: missing the tip of the iceberg?

Authors:  Olgun Elicin; Dario Terribilini; Mohamed Shelan; Werner Volken; Etienne Mathier; Alan Dal Pra; Daniel M Aebersold; Michael K Fix; Peter Manser
Journal:  Radiat Oncol       Date:  2017-06-20       Impact factor: 3.481

4.  A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study-Part 1 (Head and Neck Surgery).

Authors:  Pavel Dulguerov; Martina A Broglie; Guido Henke; Marco Siano; Paul Martin Putora; Christian Simon; Daniel Zwahlen; Gerhard F Huber; Giorgio Ballerini; Lorenza Beffa; Roland Giger; Sacha Rothschild; Sandro V Negri; Olgun Elicin
Journal:  Front Oncol       Date:  2019-10-24       Impact factor: 6.244

5.  Recurrence Patterns After IMRT/VMAT in Head and Neck Cancer.

Authors:  Heleen Bollen; Julie van der Veen; Annouschka Laenen; Sandra Nuyts
Journal:  Front Oncol       Date:  2021-09-16       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.